Estimate Recalculated Dec 3, 2025 08:04PM EST
Philippe O. Chambon does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Relypsa Inc, iRhythm Technologies, Inc., Oxford Immunotec Global PLC, CONCERT PHARMACEUTICALS, INC., MEI Pharma, Inc., Transcept Pharmaceuticals Inc, Durata Therapeutics, Inc., Versartis, Inc., CHIMERIX INC, NxStage Medical, Inc., AUXILIUM PHARMACEUTICALS INC, ICAGEN INC, EPOCRATES INC, WORLD HEART CORP, and NUVELO INC.
Philippe O. Chambon's CIK is 0001192212
2008 was Philippe O. Chambon's most active year for acquiring shares with 6 total transactions. Philippe O. Chambon's most active month to acquire stocks was the month of May. 2013 was Philippe O. Chambon's most active year for disposing of shares, totalling 4 transactions. Philippe O. Chambon's most active month to dispose stocks was the month of February. 2011 saw Philippe O. Chambon paying a total of $259,144.20 for 11,790 shares, this is the most they've acquired in one year. In 2013 Philippe O. Chambon cashed out on 55,020 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!